☰

Jacqueline C. Shultz, Ph.D. - Publications

Affiliations: 
2009 Biochemistry Virginia Commonwealth University, Richmond, VA, United States 
Area:
Molecular Biology, Biochemistry
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Shapiro BA, Vu NT, Shultz MD, Shultz JC, Mietla JA, Gouda MM, Yacoub A, Dent P, Fisher PB, Park MA, Chalfant CE. Melanoma differentiation associated gene 7/IL-24 exerts cytotoxic effects by altering the alternative splicing of Bcl-x pre-mRNA via the SRC/PKCδ signaling axis. The Journal of Biological Chemistry. PMID 27519412 DOI: 10.1074/Jbc.M116.737569  0.655
2015 Barbour SE, Nguyen PT, Park M, Emani B, Lei X, Kambalapalli M, Shultz JC, Wijesinghe D, Chalfant CE, Ramanadham S. Group VIA Phospholipase A2 (iPLA2β) Modulates Bcl-x 5'-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in β-Cells. The Journal of Biological Chemistry. 290: 11021-31. PMID 25762722 DOI: 10.1074/Jbc.M115.648956  0.631
2013 Vu NT, Park MA, Shultz JC, Goehe RW, Hoeferlin LA, Shultz MD, Smith SA, Lynch KW, Chalfant CE. HnRNP U enhances caspase-9 splicing and is modulated by AKT-dependent phosphorylation of hnRNP L Journal of Biological Chemistry. 288: 8575-8584. PMID 23396972 DOI: 10.1074/Jbc.M112.443333  0.641
2012 Shultz JC, Vu N, Shultz MD, Mba MUU, Shapiro BA, Chalfant CE. The proto-oncogene PKCι regulates the alternative splicing of Bcl-x Pre-mRNA Molecular Cancer Research. 10: 660-669. PMID 22522453 DOI: 10.1158/1541-7786.Mcr-11-0363  0.694
2012 Shultz JC, Chalfant CE. The flip-flop HuR: part of the problem or the solution in fighting cancer? The Journal of Clinical Investigation. 122: 16-9. PMID 22201677 DOI: 10.1172/Jci61677  0.582
2011 Shultz JC, Goehe RW, Murudkar CS, Wijesinghe DS, Mayton EK, Massiello A, Hawkins AJ, Mukerjee P, Pinkerman RL, Park MA, Chalfant CE. SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells. Molecular Cancer Research : McR. 9: 889-900. PMID 21622622 DOI: 10.1158/1541-7786.Mcr-11-0061  0.66
2011 Shultz JC, Chalfant CE. Caspase 9b: a new target for therapy in non-small-cell lung cancer. Expert Review of Anticancer Therapy. 11: 499-502. PMID 21504315 DOI: 10.1586/Era.11.23  0.577
2010 Shultz JC, Goehe RW, Wijesinghe DS, Murudkar C, Hawkins AJ, Shay JW, Minna JD, Chalfant CE. Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a. Cancer Research. 70: 9185-96. PMID 21045158 DOI: 10.1158/0008-5472.Can-10-1545  0.613
2010 Goehe RW, Shultz JC, Murudkar C, Usanovic S, Lamour NF, Massey DH, Zhang L, Camidge DR, Shay JW, Minna JD, Chalfant CE. hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing. The Journal of Clinical Investigation. 120: 3923-39. PMID 20972334 DOI: 10.1172/Jci43552  0.673
2007 Shultz JC, Chalfant CE. Emetine and the alternative splicing of Bcl-X: where to next? Chemistry & Biology. 14: 1313-4. PMID 18096499 DOI: 10.1016/J.Chembiol.2007.12.002  0.627
Show low-probability matches.